Search

John D. Ulm

Examiner (ID: 10769, Phone: (571)272-0880 , Office: P/1649 )

Most Active Art Unit
1649
Art Unit(s)
1649, 1812, 1646, 1805
Total Applications
2240
Issued Applications
1195
Pending Applications
205
Abandoned Applications
843

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 8059761 [patent_doc_number] => 20120079613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'Homeobox Transcription Factor BSX and Uses Thereof for Treating Diseases, in Particular Obesity' [patent_app_type] => utility [patent_app_number] => 12/296814 [patent_app_country] => US [patent_app_date] => 2007-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14122 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20120079613.pdf [firstpage_image] =>[orig_patent_app_number] => 12296814 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/296814
Homeobox Transcription Factor BSX and Uses Thereof for Treating Diseases, in Particular Obesity Apr 1, 2007 Abandoned
Array ( [id] => 6423594 [patent_doc_number] => 20100168003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'Agent for Treating Polyglutamine Aggregation-Caused Disease or Suppressing Onset Thereof' [patent_app_type] => utility [patent_app_number] => 12/226447 [patent_app_country] => US [patent_app_date] => 2007-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 17452 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20100168003.pdf [firstpage_image] =>[orig_patent_app_number] => 12226447 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/226447
Agent for treating polyglutamine aggregation-caused disease or suppressing onset thereof Mar 29, 2007 Issued
Array ( [id] => 5091692 [patent_doc_number] => 20070231331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISORDERS AND ALZHEIMER\'S DISEASE AND IMPROVING NORMAL MEMORY' [patent_app_type] => utility [patent_app_number] => 11/693926 [patent_app_country] => US [patent_app_date] => 2007-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 22119 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0231/20070231331.pdf [firstpage_image] =>[orig_patent_app_number] => 11693926 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/693926
Methods for screening agents that modulate presenilin activity and A-β production Mar 29, 2007 Issued
Array ( [id] => 5279505 [patent_doc_number] => 20090131637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'Vanilloid receptor' [patent_app_type] => utility [patent_app_number] => 11/716476 [patent_app_country] => US [patent_app_date] => 2007-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2753 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20090131637.pdf [firstpage_image] =>[orig_patent_app_number] => 11716476 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/716476
Vanilloid receptor Mar 8, 2007 Abandoned
Array ( [id] => 4445381 [patent_doc_number] => 07863433 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-04 [patent_title] => 'Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction' [patent_app_type] => utility [patent_app_number] => 11/716362 [patent_app_country] => US [patent_app_date] => 2007-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23058 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/863/07863433.pdf [firstpage_image] =>[orig_patent_app_number] => 11716362 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/716362
Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction Mar 7, 2007 Issued
Array ( [id] => 4688136 [patent_doc_number] => 20080032317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-07 [patent_title] => 'Methods for improving the function of heterlogous G protein-coupled receptors' [patent_app_type] => utility [patent_app_number] => 11/708333 [patent_app_country] => US [patent_app_date] => 2007-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7703 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20080032317.pdf [firstpage_image] =>[orig_patent_app_number] => 11708333 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/708333
Methods for improving the function of heterlogous G protein-coupled receptors Feb 20, 2007 Abandoned
Array ( [id] => 5005003 [patent_doc_number] => 20070202573 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Soluble fusion proteins comprising heterologous polypeptides' [patent_app_type] => utility [patent_app_number] => 11/705106 [patent_app_country] => US [patent_app_date] => 2007-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 26896 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20070202573.pdf [firstpage_image] =>[orig_patent_app_number] => 11705106 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/705106
Soluble fusion proteins comprising heterologous polypeptides Feb 11, 2007 Issued
Array ( [id] => 5112958 [patent_doc_number] => 20070196873 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-23 [patent_title] => 'Pain signaling molecules' [patent_app_type] => utility [patent_app_number] => 11/703062 [patent_app_country] => US [patent_app_date] => 2007-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 39115 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20070196873.pdf [firstpage_image] =>[orig_patent_app_number] => 11703062 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/703062
Pain signaling molecules Feb 4, 2007 Issued
Array ( [id] => 170260 [patent_doc_number] => 07662574 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-16 [patent_title] => 'Use of a G protein-coupled receptor and its cognizant ligand in the identification of compounds that affect prolactin secretion' [patent_app_type] => utility [patent_app_number] => 11/701719 [patent_app_country] => US [patent_app_date] => 2007-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 65815 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 339 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/662/07662574.pdf [firstpage_image] =>[orig_patent_app_number] => 11701719 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/701719
Use of a G protein-coupled receptor and its cognizant ligand in the identification of compounds that affect prolactin secretion Feb 1, 2007 Issued
Array ( [id] => 6465026 [patent_doc_number] => 20100190698 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'Neuroprotective peptide inhibitors of AP-1 signaling and uses therefor' [patent_app_type] => utility [patent_app_number] => 12/441695 [patent_app_country] => US [patent_app_date] => 2007-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 25575 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20100190698.pdf [firstpage_image] =>[orig_patent_app_number] => 12441695 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/441695
Neuroprotective peptide inhibitors of AP-1 signaling and uses therefor Jan 30, 2007 Issued
Array ( [id] => 6120874 [patent_doc_number] => 20110077204 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'Agent for Targeted Drug Delivery To Cerebral Neurons' [patent_app_type] => utility [patent_app_number] => 12/223113 [patent_app_country] => US [patent_app_date] => 2007-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7734 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20110077204.pdf [firstpage_image] =>[orig_patent_app_number] => 12223113 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/223113
Agent for Targeted Drug Delivery To Cerebral Neurons Jan 23, 2007 Abandoned
Array ( [id] => 5101228 [patent_doc_number] => 20070184490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Neuronal nicotinic receptor ligands and their use' [patent_app_type] => utility [patent_app_number] => 11/653553 [patent_app_country] => US [patent_app_date] => 2007-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12339 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20070184490.pdf [firstpage_image] =>[orig_patent_app_number] => 11653553 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/653553
Neuronal nicotinic receptor ligands and their use Jan 15, 2007 Abandoned
Array ( [id] => 5095529 [patent_doc_number] => 20070117138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-24 [patent_title] => 'SPLICE VARIANT CANNABINOID RECEPTOR (CB1B)' [patent_app_type] => utility [patent_app_number] => 11/622220 [patent_app_country] => US [patent_app_date] => 2007-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8412 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20070117138.pdf [firstpage_image] =>[orig_patent_app_number] => 11622220 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/622220
SPLICE VARIANT CANNABINOID RECEPTOR (CB1B) Jan 10, 2007 Abandoned
Array ( [id] => 288910 [patent_doc_number] => 07547523 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-16 [patent_title] => 'Histamine receptor' [patent_app_type] => utility [patent_app_number] => 11/620337 [patent_app_country] => US [patent_app_date] => 2007-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14711 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 266 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/547/07547523.pdf [firstpage_image] =>[orig_patent_app_number] => 11620337 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/620337
Histamine receptor Jan 4, 2007 Issued
Array ( [id] => 7691495 [patent_doc_number] => 20070232538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'Uses of polypeptides' [patent_app_type] => utility [patent_app_number] => 11/647076 [patent_app_country] => US [patent_app_date] => 2006-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 80869 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20070232538.pdf [firstpage_image] =>[orig_patent_app_number] => 11647076 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/647076
Uses of polypeptides Dec 26, 2006 Abandoned
Array ( [id] => 330352 [patent_doc_number] => 07510847 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-31 [patent_title] => 'Kidney-specific urate transporter and gene thereof' [patent_app_type] => utility [patent_app_number] => 11/644193 [patent_app_country] => US [patent_app_date] => 2006-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5049 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/510/07510847.pdf [firstpage_image] =>[orig_patent_app_number] => 11644193 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/644193
Kidney-specific urate transporter and gene thereof Dec 20, 2006 Issued
Array ( [id] => 5435540 [patent_doc_number] => 20090170127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'Screening Compounds for Activity in Modulating Chloride Ion Transport' [patent_app_type] => utility [patent_app_number] => 12/086726 [patent_app_country] => US [patent_app_date] => 2006-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10176 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170127.pdf [firstpage_image] =>[orig_patent_app_number] => 12086726 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/086726
Screening compounds for activity in modulating chloride ion transport Dec 17, 2006 Issued
Array ( [id] => 6477318 [patent_doc_number] => 20100285045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'Novel Neurotrophic Factor Protein and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/086397 [patent_app_country] => US [patent_app_date] => 2006-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 34538 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20100285045.pdf [firstpage_image] =>[orig_patent_app_number] => 12086397 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/086397
Novel Neurotrophic Factor Protein and Uses Thereof Dec 13, 2006 Abandoned
Array ( [id] => 4745279 [patent_doc_number] => 20080089881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'Treatment and Diagnostics of Inflammatory Diseases' [patent_app_type] => utility [patent_app_number] => 11/567341 [patent_app_country] => US [patent_app_date] => 2006-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5228 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20080089881.pdf [firstpage_image] =>[orig_patent_app_number] => 11567341 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/567341
Treatment and Diagnostics of Inflammatory Diseases Dec 5, 2006 Abandoned
Array ( [id] => 5107039 [patent_doc_number] => 20070065917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'Endogenous and non-endogenous, constitutively activated human G protein-coupled receptions' [patent_app_type] => utility [patent_app_number] => 11/603386 [patent_app_country] => US [patent_app_date] => 2006-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 19088 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 40 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20070065917.pdf [firstpage_image] =>[orig_patent_app_number] => 11603386 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/603386
Endogenous and non-endogenous, constitutively activated human G protein-coupled receptions Nov 21, 2006 Abandoned
Menu